Anti‐PrP monoclonal antibody as a novel treatment for neurogenesis in mouse model of Alzheimer's disease
Abstract Background Alzheimer's disease (AD) is the most common degenerative disease characterized by cognitive impairment, memory decline, and language disorder for which there is no effective treatment. Neurogenesis has been indicated in AD and may play an important role in the pathogenesis o...
Guardado en:
Autores principales: | Ruolin Li, Ming Ren, Yingxin Yu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cafe6ace1a4b4e5aa1e0069eb8f1fa22 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Agregados amiloides: rol en desórdenes de conformación proteica
por: Duran-Aniotz,Claudia, et al.
Publicado: (2013) -
Ethanolamine Is a New Anti-Prion Compound
por: Keiji Uchiyama, et al.
Publicado: (2021) -
Gamma Radiation-induced Impairment of Hippocampal Neurogenesis,Comparison of Single and Fractionated Dose Regimens
por: Khoshbin khoshnazar,A. R, et al.
Publicado: (2012) -
Prion Infectivity and PrP<sup>BSE</sup> in the Peripheral and Central Nervous System of Cattle 8 Months Post Oral BSE Challenge
por: Ivett Ackermann, et al.
Publicado: (2021) -
Attenuative Effects of Fluoxetine and <i>Triticum aestivum</i> against Aluminum-Induced Alzheimer’s Disease in Rats: The Possible Consequences on Hepatotoxicity and Nephrotoxicity
por: Karema Abu-Elfotuh, et al.
Publicado: (2021)